Loading organizations...
Loading organizations...
Developing therapies for orphan genetic muscle diseases using antibodies.
Valerion Therapeutics, LLC has raised $20.0M across 1 funding round.
Valerion Therapeutics, LLC has raised $20.0M in total across 1 funding round.
Valerion Therapeutics, LLC has raised $20.0M in total across 1 funding round.
Valerion Therapeutics, LLC's investors include Karen Pritzker.
Valerion Therapeutics, LLC has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in March 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 4, 2012 | $20.0M Series A | Karen Pritzker |